Neil Woodford

Neil Woodford has made a new investment in AJ Bell via a fundraising round which ensures the Invesco Perpetual-backed platform will remain a private company.

Neil Woodford has questioned the viability of the British electoral system following the surprisingly decisive result of the general election.

Eight product launches, tweaks and updates advisers should know about

Neil Woodford's Patient Capital trust has raised £800m during its offer period, a record for a London-listed investment trust.

Woodford Investment Management (WIM) has increased the initial fundraising limit for its Patient Capital trust from £500m to £800m in response to investor demand.

Neil Woodford has said next month's general election could mark the beginning of years of uncertainty for UK investors.

What fund managers should be telling advisers

Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.

Fidelity FundsNetwork is to make Neil Woodford's Patient Capital trust the first externally-managed investment trust available on the platform, in what it says is a "clear intention" of more to come.

News of Neil Woodford's forthcoming trust investing in early stage companies has prompted comparisons with venture capital trusts (VCTs), but analysts say they are unlikely to appeal to the same kinds of investors.